Document:

Exhibit

Exhibit 10(i)

FORM OF

EXECUTIVE RETENTION PHANTOM UNIT AGREEMENT

THIS EXECUTIVE RETENTION PHANTOM UNIT AGREEMENT (this “Agreement”) is by and between Magellan GP, LLC (the “Company”) and Employee Name (the “Participant”). 

		
	1.
	Grant of Phantom Units.  The Company hereby grants to the Participant effective February 1, 2016 (the “Effective Date”), subject to the terms and conditions of the Magellan Midstream Partners Long-Term Incentive Plan, as amended and restated (the “Plan”), and this Agreement, the right to be eligible to receive a grant of X,XXX Phantom Units, with tandem distribution equivalent rights (“DERs”), of Magellan Midstream Partners, L.P. (the “Partnership”).  These Units, including the tandem DERs, are referred to in this Agreement as “Phantom Units” during the Restricted Period.  Until the Phantom Units vest and are paid, the Participant shall have no rights as a unitholder of the Partnership with respect to the Phantom Units.

		
	2.
	Incorporation of Plan.  The Plan is hereby incorporated herein by reference and all capitalized terms used, but not defined, herein shall have the meanings set forth in the Plan.  The Participant acknowledges receipt of a copy of the Plan and hereby accepts the Phantom Units subject to all the terms and provisions of the Plan and this Agreement.

		
	3.
	Compensation Committee of the Board - Decisions and Interpretations.  The Participant agrees to accept as binding, conclusive and final all decisions and interpretations of the Compensation Committee of the Board (the “Committee”) of the Company with respect to any questions arising under the Plan and this Agreement.

		
	4.
	Restricted Period of Phantom Units.  The Restricted Period begins with the Effective Date and ends with the first of the following events to occur:

		
	a.
	December 31, 2018; or

		
	b.
	Your Termination of Affiliation (excluding any transfer to an Affiliate of the Company) with the Company, voluntarily for Good Reason or involuntarily (other than due to Cause), within two years following a Change of Control as set forth in the Plan.

		
	5.
	Eligibility to Receive Units.  The Participant will be eligible to receive a payment of the Phantom Units hereunder only if the Participant has been employed by the Company or its Affiliates or their successors continuously throughout the Restricted Period and continues to be so employed on the last day of the Restricted Period, unless the Participant terminates employment during the Restricted Period due to Retirement, death or Disability, in which case, the Phantom Units will vest as provided in Section 7 below.  

		
	6.
	Payment of Units.   Subject to legal or contractual obligations and Participant’s qualification to receive payment of the Phantom Units as set forth in Section 5, the Company will deliver to the Participant as soon as practicable after the Restricted Period a number of Units equal to the number of vested Phantom Units net of any units used to satisfy all or part of the minimum tax withholding requirements. The number of Phantom Units required to cover minimum tax withholding will be based on the closing price of the Units at the end of the Restricted Period.  In addition, at the end of the Restricted Period the Company will pay to the Participant the value of the DERs on the gross number of Units received pursuant to the terms of this Agreement.  The value of the DERs shall be the amount of all distributions per Unit that would have been earned and paid during the Restricted Period and no interest shall be paid on such amount.  Such payment of DERs shall be in cash and subject to minimum tax withholding requirements. 

		
	7.
	Termination of Employment Due to Retirement, Death or Disability.  In the event a Participant’s employment with the Company or its Affiliates terminates prior to the end of the Restricted Period due to Retirement, death or Disability and on the date of such termination due to Retirement, death or Disability the Participant would have met the eligibility requirements of Section 5, the initial grant of Phantom Units will be prorated based upon the Participant’s months of employment between January 1, 2016 and December 31, 2018.  Such prorated amount will continue to be restricted and subject to the terms of this Agreement until the Restricted Period ends.  All Phantom Units in excess of the prorated amount shall be forfeited.

8.   Other Provisions.
		
	a.
	The Participant understands and agrees that payments under this Agreement shall not be used for, or in the determination of, any other payment or benefit under any continuing agreement, plan, policy, practice or arrangement providing for the making of any payment or the provision of any benefits to or for the Participant or to the Participant’s beneficiaries or representatives, including, without limitation, any employment agreement, any change of control severance protection plan or any employee benefit plan as defined in Section 3(3) of ERISA, including, but not limited to qualified and non-qualified retirement plans.

		
	b.
	Except as otherwise provided herein, in the event that the Participant’s employment with the Company or its Affiliates or their successors terminates for any reason prior to the end of the Restricted Period, such Phantom Units shall be forfeited. 

		
	c.
	By signing this Agreement, the Participant represents and agrees that he or she will keep the terms, amount and fact of this Agreement completely confidential, and that, unless required to do so by law, he or she will not hereafter disclose any information concerning this Agreement to anyone including, but not limited to, any past, present or prospective employee or applicant for employment of the Company or its Affiliates and any past, present or prospective customer of the Company or its Affiliates.

		
	d.
	Neither the Phantom Units, nor the Participant’s interest in the Phantom Units, may be sold, assigned, transferred, pledged, hedged or otherwise disposed of or encumbered at any time prior to the vesting and payment of such Phantom Units under this Agreement.

		
	e.
	If the Participant at any time forfeits any or all of the Phantom Units pursuant to this Agreement, the Participant agrees that all of the Participant’s rights to and interest in the forfeited Phantom Units, including the tandem DERs, shall terminate upon forfeiture without payment of consideration.

		
	f.
	The Committee shall make the determination as to whether an event has occurred resulting in the forfeiture of the Phantom Units, in accordance with this Agreement and the Plan, and all determinations of the Committee shall be final and conclusive.

		
	g.
	With respect to the right to receive payment of the Phantom Units under this Agreement, nothing contained herein shall give the Participant any rights that are greater than those of a general creditor of the Company.

		
	9.
	Notices.  All notices to the Company required hereunder shall be in writing and delivered by hand or by mail, addressed to Magellan Midstream Partners, L.P., One Williams Center, Mail Drop 28-4, Tulsa, Oklahoma 74172, Attention: Compensation Department.  Notices shall become effective upon their receipt by the Company if delivered in the forgoing manner.

Magellan GP, LLC

                        
By: 
Michael N. Mears
President and Chief Executive Officer
Magellan GP, LLC

Dated:  February 1, 2016EXCLUSIVE
LICENSE AGREEMENT

Between

RONALD
KNIGHT

and

AVALON
OIL & GAS, INC.

 

THIS
EXCLUSIVE LICENSE AGREEMENT (the “Agreement”) entered into effective December 1,
2014 (the “Effective Date”) between Ronald Knight, an individual, with his principal office at 2300 South Dock Street,
Unit 102, Palmetto, Florida, 34221 (hereinafter referred to as “Knight")
and Avalon Oil & Gas, Inc., a Nevada Corporation, with its principal office at Suite. 7000, 310 Fourth Avenue South, Minneapolis,
Minnesota 55415 (hereinafter referred to as “LICENSEE”).

Effective
as of the date set out above, in consideration of the mutual covenants and premises contained herein, the receipt and sufficiency
of which are hereby acknowledged, Knight and LICENSEE
agree:

BACKGROUND

 

Knight
owns certain anti-corrosion trade secrets and anti-corrosion technology, LICENSEE desires to obtain rights to use the Licensed
Technology for commercial purposes and Knight desires to grant certain rights and licenses in and to the Licensed Technology to
Licensee, all in accordance with the terms and conditions of this Agreement, W.

 

ARTICLE
I. DEFINITIONS

 

When
used in this Agreement, the capitalized terms sisted below shalshave the followingmeaning: “Affiliate”
means a person or entity that directly or indirectly through one or more intermediary’s controls, is controlled by, or is
under common control, with the person or entity specified. For purposes of this definition, “control” and cognates
thereof mean, with respect to an entity, the director indirect ownership of (a) at least fifty percent (50%) of the capital stock
or share capital entitled to vote for the election of directors of the entity; or (b) at least fifty percent (50%) of equity or
voting interests of the entity, or (c) the ability to otherwise direct the management and operations

of
the entity.

 

“Agreement”
or “License Agreement” means this Agreement, including all Exhibits attached to this Agreement.

 

“Effective
Date" means the date set out on the pig paragraph of this Agreement.

 

“Field
of Use” means as they may relate to corrosion prevention and maintenance of simp pumps at gasoline and diesel dispensing
locations, including, but not himited to gas stations, convenience stores, trucking companies, bus companies, and any other locations
where gasoline and/or diesel is dispensed.

 

“Grant”
means the granting of an Exclusive License for the Field of Use in the Territory.

    	 	1	 

    	 

    

 

“Gross
Receipts” means the gross payments and other consideration accrued or received by LICENSEE for: (i) the sale or other disposition
of Licensed Products; or (ii) the performance of Licensed Services. The expression “other disposition" or “otherwise
disposed of" with respect to Licensed Products means: (a) Licensed Products not sold but delivered by LICENSEE to others
(including deliveries for export) regardless of the basis for compensation, if any; (b) Licensed Products
put into use by LICENSEE for any purpose other than routine testing of such products; and (c) Licensed Products not sold as such
but sold by LICENSEE as components or constituents of other products. Where Licensed Products are not sold, but are otherwise
disposed of Gross Receipts from such products for the purpose of computing royalties will be the selling price at which products
of a similar kind and quality, sold in similar quantities, are currently being offered for sale by LICENSEE. Where such products
are not currently being offered for sale by LICENSEE, Gross Receipts from such products for the purpose of computing royalties
will be the selling price at which products of a similar kind and quality, sold in similar quantities, are currently being offered
for sale by other manufacturers.

 

“Indemnitee's"
means Knight, and employees, officers and directors of any affiliate entity controlled by Knight, and the Inventors, and their
respective heirs, executors, administrators, and legal representatives.

 

“Licensed
Products” means products, process for application of products, the development, manufacture, use, or sale of which would,
but for the license granted to LICENSEE under this Agreement, infringing on the use of Licensed Technology.

 

“Licensed
Services” means services that make use of the Licensed Patents or the Licensed Technology in a manner which would, but for
the license granted to LICENSEE under this Agreement, infringe a Valid Claim or which involves the use of Licensed Technology,
or that utilize or consume Licensed Products.

 

“Licensed
Technology” means all technical information, including Trade Secrets, knownto Knight or more Inventors that is, as of the
date of this Agreement, legally vested in Knight, and within the scope of the disclosure of Licensed Technology set forth in attached
Exhibit A.

 

“Licensed
Territory” means the World.

 

“Trade
Secrets” means all intellectual property related to production of products and the process of
application of the products for underground fuel storage tank sump pumps to mitigate the corrosion.

ARTICLE
II. GRANT OF LICENSE

2.1
Subject to the terms and conditions of this Agreement, Knight grants to LICENSEE, to the extent of the Field of Use and Licensed
Territory, a license under the Licensed Technology, to:
(i) make from concentrate, use, sell, offer for sale, and import Licensed Products and Process and to provide Licensed Services.
The license granted to LICENSEE under this

    	 	2	 

    	 

    

Products
and Process and to provide Licensed Services. The license granted to LICENSEE under this Section 2.1 is exclusive with respect
to the Licensed Technology (subject to the reservations set out in Section 24, below). 

2.2
Except as expressly granted by Knight to LICENSEE herein, all rights and entitlements, whether now existing or that may hereafter
come into existence, are reserved to Knight.

2.3
This Agreement shall be construed to construed rights upon LICENSEE by implication or estoppel.

2.4
LICENSEE acknowledges and consents that, notwithstanding any provision of this Agreement, Knight retains the ownership of the
technology, products, and the process being licensed by the LICENSEE. Knight further agrees he will not sell or compete with the
products and/or process in the field of use which is the subject of this license nor release the trade secrets.

ARTICLE
II. DILIGENCE AND COMMERCIALIZATION 

 

3.1
Diligence and Commercialization. Throughout the term of this Agreement, LICENSEE shall use commercially reasonable efforts to
bring Licensed Products and Licensed Services, in the Field of Use, to market. In no instance shall LICENSEE'S commercially reasonable
best efforts be less than efforts customary in LICENSEE'S industry,

3.2
Lack of Diligence. The LICENSEE shall have twenty-four (24) months to demonstrate to Knight that the Licensed Technology is being
reasonably commercialized and as a milestone Knight shall receive a minimum of Sixty Thousand Dollars ($60,000) per year of royalty
fees commencing in the twenty-fifth (25*) month of this agreement.

3.3 Financial Capability. At all times during the term of this
license, LICENSEE shall maintain the financial capability to comply with Section 3.1. Upon inquiry from Knight regarding said
capability, LICENSEE shall provide Knight with information regarding LICENSEE's financial capabilities and shall permit Knight
to inspect LICENSEE's financial records, only limited by regulatory rules and regulations.

 

ARTICLE
IV. CONSIDERATION FOR LICENSE AND ROYALTIES 

 

4.1
License Fee. In addition to all other amounts due to Knight under this Article IV, LI, in consideration of entering into
this Agreement, Knight shall receive Three Hundred Thousand
(300,000) of unregistered common shares of LICENSEE as an initial license % fee. In addition, the LICENSEE shall pay to Knight
three percent (3%) of the Gross Receipts received by the LICENSEE.

4.2
Consulting Ees Knight agrees to provide fifty (50) hours of consulting concerning the products and process in the first
ninety (90) days from the implementation of this license, Knight will be paid at the fate of $200 per hour for any subsequent
consulting provided by Knight.

 

    	 	3	 

    	 

    

 

4.3 Concentrate.
In return for Knight supplying the concentrate as required under this LICENSEE shall pay to Knight mutually agreed upon
amount for said product.

 

ARTICLE
V. REPORTS AND PAYMENTS

 

5.1
Not later than the last day of each January, April, July, and October during the term of this Agreement, LICENSEE shall
deliver to Knight a written report stating for the quarterly period ended the last days of the preceding December, March,
June, and September, respectively:

(a)
for Licensed Products, the number of units sold;

(b) for Licensed Services, a description of the Services provided;

(c)
such other detail as Knight may reasonably require from time to time, including any results related to the use of the
Licensed Technology.

 

ARTICLE
VI. RECORDS

 

6.1
Records of Operations and Audit, LICENSEE and its Commercial Sublicensees shall keep full and accurate records containing
particulars that may be necessary for the purpose of verifying the quality of the Licensed Technology including longevity of success
in its use.

 

ARTICLE
VII. MAINTENANCE/LICENSEE DISPUTES

 

7.1 Maintenance
of Licensed Technology, The maintenance of the Licensed Trade Secrets shall be the primary responsibility of and
controlled by Knight, Knight shall keep LICENSEE reasonably informed as to material developments with respect to the
Licensed Trade Secrets, Knight hereby agrees to place the Licensed Technology and Trade Secrets in escrow with a third party
mutually acceptable to the parties of this agreement. The Licensed Technology and Trade Secrets placed in escrow shall
provide the details to make the products subject of this license and also the process for producing and applying the
technology subject to this license. The escrow shall be released to the LICENSEE (1) upon the consent of Knight, or (2) upon
the death or disability of Knight, or (3) upon a material breach of this Agreement preventing him to produce the necessary
products subject to this license.

7.2
Licensee Technology Dispute. With respect to any assertion or claim by LICENSEE of the invalidity, unenforceability,
or non-infringement of a Licensed Technology (a Licensee Dispute):

    	 	4	 

    	 

    

(a)
LICENSEE will bring to Knight's attention should it be determined that another entity or individual has obtained the trade secret
of the Licensed Technology, LICENSEE will disclose such prior art or other information to Knight at the time it learns thereof,
and not less than ninety (90) days prior to bringing any action, arbitration, or proceeding against Knight arising out of a Licensee
dispute,

 

ARTICLE
VIII. INFRINGEMENT

 

8.1
Each party shall promptly give written notice to the other party of: (i) any suspected infringement of a Licensed
Technology; (ii) the threat of or filing of any declaratory judgment action by a third party alleging the invalidity,
unenforceability, or non-infringement of the Licensed Technology.

8.2
LICENSEE shall have the first right (but not the obligation) to notify an entity or individual of using the Trade Secrets
and initiate legal proceedings to abate the infringement of a Licensed Technology within LICENSEE'S Field of Use, Knight
agrees to join as a party plaintiff in any such lawsuit initiated by LICENSEE, if requested to do so by LICENSEE, with all
costs, attorneys' fees, and expenses of Knight to be paid by LICENSEE. Should LICENSEE elect not to institute such an action
to enforce the Licensed Technology against infringement within LICENSEE's Field of Use within ninety (90) days after receipt
of written notice from Knight of Knight's intention to bring suit for such infringement, Knight shall have the right
(but not the obligation) at its own expense to take those steps on behalf of itself and LICENSEE, provided that LICENSEE
shall have the right to participate at its own expense in any action brought by Knight.

8.3
If LICENSEE leads proceedings to abate and remedy infringement, any monetary recovery from the infringement of Licensed
Technology received by LICENSEE shall first be applied to reimburse LICENSEE's unreimbursed expenses of such proceedings and
then Knight's unreimbursed expenses of such proceedings, including without limitation, reasonable attorneys’ fees and
court costs. If Knight leads proceedings to abate and remedy infringement, any monetary recovery from the infringement of
Licensed Technology shall be first applied to reimburse Knight's unreimbursed expenses of such proceedings, and then
LICENSEE’s unreimbursed expenses of such proceedings, including without limitation, reasonable attorneys’ fees
and court costs. Any remainder shall, to the extent the same pertains to an infringement of the Licensed Technology shall be
divided between the LICENSEE and Knight as mutually agreed.

ARTICLE
IX. CONFIDENTIALITY 

 

9.1
Except as provided herein, Knight shall maintain in confidence, and shall not use for any purpose or disclose to any third
party, information disclosed by or on behalf of LICENSEE or an Affiliate in writing and marked “Confidential” or
that is disclosed by or on behalf of LICENSEE or an Affiliate orally and confirmed in writing as confidential within
forty-five (45) days following such disclosure (collectively, “Confidential Information”). Confidential
Information shall not include any information that is: (i) already known to

    	 	5	 

    	 

    

the
receiving party at the time of disclosure hereunder, or (ii) now or hereafter becomes publicly known other than through acts
or omissions of the receiving party, or (iii) is disclosed to the receiving party by a third party under no obligation of
confidentiality to the disclosing party or (iv) independently developed by the receiving party without reliance on the
Confidential Information of the disclosing party,

 

9.2
Neither party shall, without the express written consent of the other, for any reason or at any time either during or
subsequent to the term of this Agreement disclose to third parties the financial terms set forth in this Agreement, except
upon a subpoena or other court order made with appropriate provision for protection of confidential information or as
required by securities or other applicable laws or to advisors (including financial advisors, attorneys and accountants),
potential and existing investors, and others on a need to know basis, in each case under circumstances that reasonably
protect the confidentiality thereof.

 

ARTICLE
X. LIMITED WARRANTY MERCHANTABILITY AND EXCLUSION OF WARRANTIES

 

10.1
Each Party warrants to the other that it has the right and power to enter into this Agreement. Knight represents, in good
faith and to the best of its knowledge, that: (i) there are not, as of the date of the Effective Date, any claims, demands,
suits, or judgments against it that in any manner would or might impair or interfere with Knight's performance of the license
granted by Knight to LICENSEE under this Agreement. Knight does not warrant the content contained in the Licensed Licensed
Technology or that it will be error free or that any defects will be corrected. Knight makes no representation whatsoever
with regard to the scope or commercial potential or profitability or income of or from the Licensed Technology or that such
Licensed Technology may be exploited by LICENSEE without infringing any rights of any other party. Knight makes no covenant
either to defend any infringement charge by a third party or to institute action against infringers of Licensed Licensed
Technology. Knight does not warrant that the Licensed Licensed Technology will meet LICENSEE's or any of LICENSEE's
customer's specific requirements. LICENSEE warrants that it possesses the necessary expertise and skill to make, and has
made, its own evaluation of the capabilities, safety, utility, and commercial application of the Licensed Licensed
Technology.

10.2
ACCORDINGLY, THE LICENSED TECHNOLOGY IS PROVIDED “AS IS.” KNIGHT MAKES NO REPRESENTATION OR WARRANTY OF ANY KIND WITH
RESPECT TO THE LICENSED TECHNOLOGY AND EXPRESSLY DISCLAIMS ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE
AND ANY OTHER IMPLIED WARRANTIES WITH RESPECT TO THE CAPABILITIES, SAFETY, UTILITY, OR COMMERCIAL APPLICATION OF THE LICENSED
TECHNOLOGY.

 

ARTICLE XI.
DAMAGES, INDEMNIFICATION, AND INSURANCE

11.1
LICENSEE shall defend, indemnify and hold the Indemnitees harmless from any and all claims, demands, actions and causes of
action against the Indemnitees, and each of them,

    	 	6	 

    	 

    

 

whether
groundless or not, in connection with any and all injuries, losses, damages or liability of any kind whatsoever arising, directly
or indirectly, out of use, exploitation, distribution, or sale of Licensed Technology or Licensed Products by or through the LICENSEE
or its Affiliates or Commercial Sublicensees, whether or not the claims, demands, actions or causes of action are alleged to have
resulted in whole or in part from the negligent acts or omissions of an Indemnitee, or from acts or omissions of such persons
for which an Indemnitee would otherwise be strictly liable. This indemnification obligation shall include, without limiting the
generality of the foregoing, reasonable attorney fees and other costs or expenses incurred in connection with the defense of any
and all such claims, demands, actions, or causes of action.

11.2
Without limiting LICENSEE's indemnity obligations, within ninety (90) days of the commercial distribution of any Licensed Product
or provision of Licensed Services, or, if applicable, on the date of initiation of any human trials, whichever occurs sooner,
LICENSEE shall acquire aliability insurance policy and shall further maintain said policy throughout the term of this Agreement
and for five (5) years thereafter, said policy to cover each Indemnited as a named insured (with fight to prior notice of cancellation)
for all liabilities, claims, damages, and actions arising from or relating to LICENSEE’s exercise of its license under this
Agreement, including but not limited to product liability and other matters within the scope of LICENSEE’s indemnity obligations
under this Agreement, said coverage to be in an amount no less than One Million Dollars ($1,000,000) per occurrence for bodily
injury and Two Million Dollars ($2,000,000) per occurrence for property damage, subject to a reasonable aggregate amount.

Knightshall
promptly notify LICENSEE of each claim, demand, action and cause of action for which Knight or any Indemnitee intends to claim
indemnification under Section 11.1 and provide, to the extent that such an evaluation is reasonably possible by Knight, LICENSEE
with Knight's good-faith evaluation of the claim, demand, action or cause of action.

11.3
Limitation of Liability, NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY OR ANY THIRD PARTY FOR ANY SPECIAL, CONSEQUENTIAL,
EXEMPLARY OR INCIDENTAL DAMAGES (INCLUDING LOST OR ANTICIPATED REVENUES OR PROFITS RELATING TO THE SAME), ARISING FROMANY CLAIMRELATING
TO THIS AGREEMENT, WHETHER SUCH CLAIM IS BASED ON CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, EVEN IF AN AUTHORIZED REPRESENTATIVE
OF SUCH PARTY IS ADVISED OF THE POSSIBILITY OR LIKELIHOOD OF SAME.

 

ARTICLE
XII. TERM AND TERMINATION

 

12.1
Term. Unless otherwise extended in writing by mutual agreement of the Parties, this Agreement will remain valid and in
force for twenty (20) years from the date of the first sale of a Licensed Product or provision of a Licensed Service by LICENSEE.
The LICENSEE shall have the right to extend this license agreement for another twenty (20 years as long as the LICENSEE is in
compliance with this license agreement.

    	 	7	 

    	 

    

12.2
Termination
by LICENSEE, LICENSEE shall have the right to terminate this Agreement at any time, upon ninety (90) days prior written notice,
without cause and for any reason. If LICENSEE terminates this Agreement under this provision, Knight will not be under any obligation
to return any portion of the consideration paid by LICENSEE to Knight. Specifically, if the LICENSEE terminates this Agreement
and has procession of the Trade Secrets, the LICENSEE cannot continue to use the Trade Secrets without continuing to make the
license fees as required in this Agreement.

12.3
Termination by Knight. In the event of material breach of this Agreement by LICENSEE, Knight may at any time provide written
notice to LICENSEE of such material breach. If LICENSEE fails to cure the identified material breach within thirty (30) days after
the date of the notice, Knight may by written notice given to LICENSEE terminate this Agreement, A “material breach”
of this Agreement for purposes of this Section 12.3 would include, the failure to make the reports required under Article V of
this Agreement on time or the failure to make the payments or deliveries required under Article IV of this Agreement on time,

12.4
LICENSEE's Financial Condition. LICENSEE shall immediately notify Knight in writing of its intent to: (a) liquidate and/or
cease to carry on its business, (b) become “insolvent” (as such term is defined in the United States Bankruptcy Code,
as amended from time to time), or (c) voluntarily seek, consent to or acquiesce in the benefits of any bankruptcy or similar debtor-relief
laws within thirty (30) days of such action. Upon receipt of such notice, Knight may, at its sole option, terminate this Agreement
without prejudice to any other remedy to which Knight may be entitled at law or in equity or elsewhere under this Agreement, by
giving written notice of termination to LICENSEE, Failure by LICENSEE to provide such notice of intent will be deemed a material,
pre-petition, incurable breach of this Agreement and the Agreement will terminate automatically on the date of such voluntary
or involuntary petition in bankruptcy,

12.5 Effect
of Termination on Commercial Sublicenses. Upon termination of the Agreement, any Commercial Sublicenses
granted hereunder shall survive, provided that; at the time of such termination, the Commercial Sublicensee of the Commercial
Sublicense is not in material default under the Commercial Sublicense; under such Commercial Sublicense the duties and
obligations of Knight to the Commercial Sublicensee under the Commercial Sublicense are not greater than the duties and
obligations of Knight under this Agreement; and, upon request by Knight, such Commercial Sublicensee promptly agrees in
writing to render to Knight any performance, including the payment of money due from the Commercial Sublicensee under this
Agreement, after the termination and to be bound by the applicable terms of this Agreement,

12.6 Effect
of Termination on LICENSEE. If this Agreement is terminated for any reason whatsoever, LICENSEE shall return, or
at Knight's direction destroy, all plans, drawings, papers, notes, writings and other documents, Samples, organisms,
biological materials and models pertaining to the Licensed Licensed Technology, retaining no copies, and shall refrain from
using or publishing any portion thereof. Upon termination of this Agreement, LICENSEE shall cease manufacturing, processing,
producing, using, or selling Licensed

    	 	8	 

    	 

    

14.2
Arbitration. Any controversy or claim arising under or related to this Agreement shall be settled by arbitration in Tampa,
Florida before a single arbitrator in accordance with the Rules of the American Arbitration Association, Judgment on the award
rendered by the arbitrator may be entered in any court having jurisdiction thereof.

14.3
Legal Compliance. LICENSEE shall comply with all laws and regulations relating to its manufacture, processing, producing,
use, Selling, or distributing of Licensed Products. LICENSEE shall not take any action that would cause Knight or LICENSEE to
violate any laws and regulations.

14.4
Independent Contractor. LICENSEE's relationship to Knight shall be that of a licensee only, LICENSEE shall not be the agent
of Knight and shall have no authority to act for or on behalf of Knight in any matter, Persons retained by LICENSEE as employees
or agents shall not by reason thereof be deemed to be employees or agents of Knight.

14.5
INTENTIONALLY OMITTED

14.6
Use of Names. LICENSEE shall obtain the prior written approval of Knight or the Inventors prior to making use of their
names for any commercial purpose, except as required by law. As an exception to the foregoing, both LICENSEE and Knight shall
have the right to publicize the existence of this Agreement; however, neither LICENSEE nor Knight shall disclose the terms and
conditions of this Agreement without the other party's consent, except as required by law. 

Knight acknowledges this
Agreement will be filed by LICENSEE in a Form 8-K with the Securities and Exchange Commission by an affiliate of the LICENSEE
since this Agreement is an integral component of the filing by an affiliate of the LICENSEE,

14.7 Place
of Execution. This Agreement and any subsequent modifications or amendments hereto shall be deemed to have been
executed in the State of Florida, U.S.A.

14.8
Governing Law. This Agreement and all amendments, modifications, alterations, or supplements hereto, and the rights of
the parties hereunder, shall be construed under and governed by the laws of the State of Florida and the United States of America.

14.9
Entire Agreement. This Agreement constitutes the entire agreement between Knight and LICENSEE with respect to the subject
matter hereof and shall not be modified, amended or terminated except as herein provided or except by another agreement in writing
executed by the parties hereto,

14.10
Severability. All rights and restrictions contained herein may be exercised and shall be applicable and binding only to
the extent that they do not violate any applicable laws and are intended to be limited to the extent necessary so that they will
not render this Agreement illegal, invalid or unenforceable. If any provision or portion of any provision of this Agreement not
essential to the commercial purpose of this Agreement shall be held to be illegal, invalid or unenforceable by a court of competent
jurisdiction, it is the intention of

    	 	9	 

    	 

    

Products
and cease providing Licensed Services; provided, however, that LICENSEE may continue to sell in the ordinary course of
business for a period of three (3) months reasonable quantities of Licensed Products that are fully manufactured and in
LICENSEE's normal inventory at the date of termination if (a) all monetary obligations of LICENSEE to Knight have been
satisfied, and (b) royalties on such sales are paid to Knight in the amounts and in the manner provided in this Agreement.
However, nothing herein shall be construed to release either party of any obligation that matured prior to the effective date
of such termination.

12.7 Survival
of Provision on Termination. The word “termination” and cognate words such as “term” and
“terminate” as used in this Article and elsewhere in this Agreement are to be read as omitting from their
effect the following rights and obligations, all of which shall survive any termination to the degree reasonably necessary to
permit their fulfillment or discharge.

(a)
LICENSEE’s obligation to provide financial reports pursuant to Article V, to pay any amounts due hereunder through the date
of termination pursuant to Article IV, LICENSEE’s obligation to reimburse Knight for legal expenses incurred prior to the
date of termination, and LICENSEE'S other obligations under Article V of this Agreement;

(b)
Any cause of action or claim of Knight accrued, or to accrue, because of any breach or default by LICENSEE, and

(c)
The provisions of Articles IX, X, XI, XII, XIV and XV of this Agreement.

 

ARTICLE
XIII. ASSIGNMENT

 

This
Agreement shall be binding upon and shall inure to the benefit of the legal representatives and assigns of Knight and LICENSEE,
provided, however, that any assignment of this Agreement by LICENSEE to a third party may be made only upon prior written consent
of Knight, which consent may be withheld or conditioned by Knight as necessary to prevent prejudice to the Licensed Technology
and to preserve the value of the consideration promised by LICENSEE to Knight under this Agreement, LICENSEE specifically is permitted
to assign to any entity in which it has an affiliation.

 

ARTICLE
XIV. MISCELLANEOUS

 

14.1
Export Controls. LICENSEE acknowledges that Knight is subject to United States laws and regulations controlling the
export of technical data, computer software, laboratory prototypes, and other commodities and that Knight's obligations under
this Agreement are contingent upon compliance with applicable United States export laws and regulations. The transfer of
technical data and commodities may require a license from the cognizant agency of the United States government or written
assurances by LICENSEE that LICENSEE shall not export data or commodities to certain foreign countries without the prior
approval of certain United States agencies. Knight neither represents that an export license shall not be required nor that,
if required, such export license shall issue,

 

    	 	10	 

    	 

    

the
parties that the remaining provisions or portions thereof shall constitute their agreement with respect to the subject matter
hereof, and all such remaining provisions or portions thereof shall remain in full force and effect. To the extent legally permissible,
any illegal, invalid or unenforceable provision of this Agreement shall be replaced by a valid provision that will implement the
commercial purpose of the illegal, invalid or unenforceable provision. In the event that any provision essential to the commercial
purpose of this Agreement is held to be illegal, invalid or unenforceable and cannot be replaced by a valid provision that will
implement the commercial purpose of this Agreement, this Agreement and the rights granted herein shall terminate.

14.11
Force Majeure. Any delays in, or failure of performance of any party to this Agreement shall not constitute default hereunder,
or give rise to any claim for damages, if and to the extent caused by occurrences beyond the control of the party affected, including,
but not limited to, acts of God, strikes or other work stoppages; civil disturbances, fires, floods, explosions, riots, war, rebellion,
sabotage, acts of governmental authority or failure of governmental authority to issue licenses or approvals that may be required.
Any nonperformance or delay of LICENSEE subject to this Section 14.11 that is in excess of one hundred eighty (180) days will
constitute a material breach of this Agreement under

Section
12.3.

ARTICLE
XV. NOTICES

 

All
notices and other communications shall be hand delivered, sent by private overnight mail service, or sent by registered or certified
U.S. mail, postage prepaid, return receipt requested, and addressed to the party to receive such notice or other communication
at the address given below, or such other address as may hereafter be designated by notice in writing:

 

	 	If to Knight:	Ronald Knight
	 	 	2300 South Dock Street, Unit 102
	 	 	Palmetto, Florida 34221
	 	 	Telephone: 813-831-4006
	 	 	Facsimile: 813-831-1238
	 	 	 
	 	If to LICENSEE:	Kent Rodriguez
	 	 	President
	 	 	Avalon Oil & Gas, Inc.
	 	 	310 Fourth Avenue South, Suite 7000
	 	 	Minneapolis, Minnesota 55415
	 	 	Telephone: 612-315-5068
	 	 	Facsimile: 952-746-5216

Such
notices or other communications shall be effective upon receipt by an employee, agent or representative of the receiving party
authorized to receive notices or other communications sent or delivered in the manner set forth above.

    	 	11	 

    	 

    

IN
WITNESS WHEREOF, KNIGHT and LICENSEE have caused this Agreement to be signed by their duly authorized representatives,
under seal, as of the day and year indicated above.

	Date:	12/16/2014	 	Date:	11/28/2014
	 	 	 
	RONALD KNIGHT	 	LICENSEE
	 	 	 
	By:	/s/ Ronald Knight	 	By:	/s/ Kent Rodriguez
		 	 
	Printed Name: Ronald Knight	 	Printed Name: Kent Rodriguez, President

 

ACKNOWLEDGEMENT

The
undersigned, Ronald Knight, who is the Inventor and Licensor under this agreement, hereby acknowledges the terms and
conditions as set forth in this Agreement, and further agrees to comply with these terms and conditions as set forth herein.
In addition, the undersigned, as sole shareholder, officer, and director of other business units hereby agrees to hold the
Licensee harmless for any claims that may be made by any of these business units.

	Date:	12/16/2016	 	/s/ Ronald Knight
	 	 	Ronald Knight
	 	 	 

 

    	 	12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00254-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00254-of-00352.parquet"}]]